Endometrial Cancer
An Interventional Phase 3, Open-Label, Randomized Study To Evaluate Efficacy and Safety of PF-08634404 In Combination With Chemotherapy Versus Pembrolizumab In Combination With Chemotherapy In Adult Participants With Advanced Or Recurrent Mismatch Repair Proficient Endometrial Cancer - C6461018
- Details
ClinicalTrials.gov ID:
NCT07578649
Diagnosis Type:
NA
USOR Number:
- Address
,
P: